Press Releases from 2012
Reinach, Switzerland, 9 May 2012 – The Annual General Meeting of Evolva Holding SA (SIX: EVE) has approved all proposals put forward by the Board of Directors.
Reinach, Switzerland, 3 May 2012 – Evolva Holding SA (SIX: EVE) today announced that it has expanded its collaboration with International Flavors & Fragrances Inc. (NYSE: IFF), one of the world’s leading creators and manufacturers of flavours and fragrances for consumer products.
Reinach, Switzerland, 22 March 2012 – Evolva Holding SA (SIX: EVE) today announced its financial results for the period 1 January to 31 December 2011. The annual report is available on Evolva’s website.
Download:
Reinach, Switzerland, 5 March 2012 - Evolva Holding SA (SIX: EVE) today announced that Chief Scientific Officer Prof. Jutta Heim, will present data on Evolva’s promising novel antibiotic EV-035 at the conference “Superbugs & Superdrugs – A Focus on Antibacterials” in London on Monday 5 March 2012, at 1.45 PM (GMT).
Reinach, Switzerland, 29 February 2012 - Evolva Holding SA (SIX: EVE) today announced that its project with the US Army Research Office (ARO), conducted as part of the Transformational Medical Technology Initiative’s mission to prevent and address biowarfare threats, has been completed successfully.
Reinach, Switzerland, 2 January 2012 - Evolva Holding SA (SIX: EVE) today announced the signing of an agreement with Roquette Frères SA for joint research and development of novel and optimised biosynthetic production routes for an ingredient with important applications in food products. Roquette is a world leader in the area of nutrition and other products based on raw vegetable materials.
Press & Investors
Nutrition & Consumer
Pharmaceuticals
Existing Partners
